Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Elisa Perciballi"'
Autor:
Angela D'Anzi, Elisa Perciballi, Giorgia Ruotolo, Daniela Ferrari, Antonietta Notaro, Ivan Lombardi, Maurizio Gelati, Katia Frezza, Laura Bernardini, Isabella Torrente, Alessandro De Luca, Vincenzo La Bella, Angelo Luigi Vescovi, Jessica Rosati
Publikováno v:
Stem Cell Research, Vol 63, Iss , Pp 102835- (2022)
Amyotrophic Lateral Sclerosis (ALS) is a fatal disease affecting both upper and lower motoneurons. The transactive response DNA binding protein (TARDBP) gene, encoding for TDP-43, is one of the most commonly mutated gene associated with familial case
Externí odkaz:
https://doaj.org/article/71dbdaeeab21417695fd1e91315f940f
Autor:
Angela D'Anzi, Filomena Altieri, Elisa Perciballi, Daniela Ferrari, Barbara Torres, Laura Bernardini, Serena Lattante, Mario Sabatelli, Angelo Luigi Vescovi, Jessica Rosati
Publikováno v:
Stem Cell Research, Vol 53, Iss , Pp 102356- (2021)
Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative condition with phenotypic and genetic heterogeneity. It is characterized by the selective vulnerability and the progressive loss of the neural population. Here, an induced pluripot
Externí odkaz:
https://doaj.org/article/98b0bf5db00147a68d97e9c645d39984
Autor:
Elisa Perciballi, Federica Bovio, Jessica Rosati, Federica Arrigoni, Angela D’Anzi, Serena Lattante, Maurizio Gelati, Fabiola De Marchi, Ivan Lombardi, Giorgia Ruotolo, Matilde Forcella, Letizia Mazzini, Sandra D’Alfonso, Lucia Corrado, Mario Sabatelli, Amelia Conte, Luca De Gioia, Sabata Martino, Angelo Luigi Vescovi, Paola Fusi, Daniela Ferrari
Publikováno v:
Antioxidants, Vol 11, Iss 5, p 815 (2022)
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the loss of the upper and lower motor neurons (MNs). About 10% of patients have a family history (familial, fALS); however, most patients seem to develop the sp
Externí odkaz:
https://doaj.org/article/c7496b1741b1406ba8c04a056c40302d
Autor:
Angela D'Anzi, Filomena Altieri, Elisa Perciballi, Daniela Ferrari, Laura Bernardini, Marina Goldoni, Letizia Mazzini, Fabiola De Marchi, Alice Di Pierro, Sandra D'Alfonso, Maurizio Gelati, Angelo Luigi Vescovi, Jessica Rosati
Publikováno v:
Stem Cell Research, Vol 47, Iss , Pp 101924- (2020)
Among the known causative genes of familial ALS, SOD1 mutation is one of the most common. It encodes for the ubiquitous detoxifying copper/zinc binding SOD1 enzyme, whose mutations selectively cause motor neuron death, although the mechanisms are not
Externí odkaz:
https://doaj.org/article/53fff5b45f3e4e968a42757457435ca7
Autor:
Jessica Rosati, Daniela Ferrari, Angela D'Anzi, Elisa Perciballi, Mario Sabatelli, Filomena Altieri, Angelo L. Vescovi, Laura Bernardini, Barbara Torres, Serena Lattante
Publikováno v:
Stem Cell Research, Vol 53, Iss, Pp 102356-(2021)
Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative condition with phenotypic and genetic heterogeneity. It is characterized by the selective vulnerability and the progressive loss of the neural population. Here, an induced pluripot
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 21, Iss 8433, p 8433 (2020)
Volume 21
Issue 22
International journal of molecular sciences
21 (2020): 1–16. doi:10.3390/ijms21228433
info:cnr-pdr/source/autori:Luciano A.M.; Perciballi E.; Fiore M.; Del Bufalo D.; Tata A.M./titolo:The combination of the m2 muscarinic receptor agonist and chemotherapy affects drug resistance in neuroblastoma cells/doi:10.3390%2Fijms21228433/rivista:International journal of molecular sciences (Print)/anno:2020/pagina_da:1/pagina_a:16/intervallo_pagine:1–16/volume:21
International Journal of Molecular Sciences, Vol 21, Iss 8433, p 8433 (2020)
Volume 21
Issue 22
International journal of molecular sciences
21 (2020): 1–16. doi:10.3390/ijms21228433
info:cnr-pdr/source/autori:Luciano A.M.; Perciballi E.; Fiore M.; Del Bufalo D.; Tata A.M./titolo:The combination of the m2 muscarinic receptor agonist and chemotherapy affects drug resistance in neuroblastoma cells/doi:10.3390%2Fijms21228433/rivista:International journal of molecular sciences (Print)/anno:2020/pagina_da:1/pagina_a:16/intervallo_pagine:1–16/volume:21
One of the major limits of chemotherapy is depending on the ability of the cancer cells to elude and adapt to different drugs. Recently, we demonstrated how the activation of the M2 muscarinic receptor could impair neuroblastoma cell proliferation. I
Autor:
Marina Goldoni, Sandra D'Alfonso, Fabiola De Marchi, Letizia Mazzini, Elisa Perciballi, Daniela Ferrari, Angela D'Anzi, Alice Di Pierro, Maurizio Gelati, Angelo Luigi Vescovi, Filomena Altieri, Jessica Rosati, Laura Bernardini
Publikováno v:
Stem Cell Research, Vol 47, Iss, Pp 101924-(2020)
Among the known causative genes of familial ALS, SOD1 mutation is one of the most common. It encodes for the ubiquitous detoxifying copper/zinc binding SOD1 enzyme, whose mutations selectively cause motor neuron death, although the mechanisms are not